Amarin Settlement With Apotex An 'Incremental Positive,' Says Stifel
June 17, 2020 at 12:09 PM EDT
Stifel analyst Derek Archila reiterates his Hold rating on Amarin shares after the company settled with Apotex regarding its ANDA application for generic Vascepa.